Recently, several studies have investigated the clinicopathological and prognostic significance of XRCC1 in human cancers including gastric cancer, ovarian cancer, and non-small cell lung cancer (Wang et al., 2012; Abdel-Fatah et al., 2013; Liu et al., 2015). This evidence concerns the gene XRCC1 and cancer.